16 October 2015 (Friday) - New BCSH Guidelines

An email came today telling me of new guidelines that have recently been published:

  • Use of JAK inhibitors in the management of myelofibrosis - revised
  • Modification of BCSH diagnostic criteria for essential thrombocythaemia
  • Interim statement BCSH CLL guideline
  • Diagnosis and management of Aplastic Anaemia
  • Guidelines on the identification and management of pre-operative anaemia
  • Investigation and management of Nodular Lymphocyte predominant Hodgkin's Lymphoma
Some are of direct relevance to me; others not so. But one of the more informative emails I’ve received recently

No comments:

Post a Comment